Cargando…
Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: Implications for respiratory transmission and latency
BACKGROUND: Merkel cell polyomavirus (MCPyV) was discovered recently. It is considered a potential causative agent of Merkel cell carcinoma, a life-threatening skin cancer. OBJECTIVES: To study the prevalence of MCPyV in a large number of clinical samples of various types. Most of the samples were e...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172143/ https://www.ncbi.nlm.nih.gov/pubmed/19464943 http://dx.doi.org/10.1016/j.jcv.2009.04.008 |
_version_ | 1783524198008750080 |
---|---|
author | Kantola, Kalle Sadeghi, Mohammadreza Lahtinen, Anne Koskenvuo, Minna Aaltonen, Leena-Maija Möttönen, Merja Rahiala, Jaana Saarinen-Pihkala, Ulla Riikonen, Pekka Jartti, Tuomas Ruuskanen, Olli Söderlund-Venermo, Maria Hedman, Klaus |
author_facet | Kantola, Kalle Sadeghi, Mohammadreza Lahtinen, Anne Koskenvuo, Minna Aaltonen, Leena-Maija Möttönen, Merja Rahiala, Jaana Saarinen-Pihkala, Ulla Riikonen, Pekka Jartti, Tuomas Ruuskanen, Olli Söderlund-Venermo, Maria Hedman, Klaus |
author_sort | Kantola, Kalle |
collection | PubMed |
description | BACKGROUND: Merkel cell polyomavirus (MCPyV) was discovered recently. It is considered a potential causative agent of Merkel cell carcinoma, a life-threatening skin cancer. OBJECTIVES: To study the prevalence of MCPyV in a large number of clinical samples of various types. Most of the samples were examined also for the other newly found polyomaviruses KI (KIPyV) and WU (WUPyV). STUDY DESIGN: Altogether 1390 samples from immunocompetent or immunocompromised patients, including (i) tonsillar tissues and sera from tonsillectomy patients; (ii) nasopharyngeal aspirates (NPAs) and sera from wheezing children and (iii) nasal swabs, sera and stools from febrile leukemic children were studied for MCPyV. The tonsils, nasal swabs and stools were also studied for KIPyV and WUPyV. RESULTS: MCPyV DNA was detected in 14 samples altogether; 8 of 229 (3.5%) tonsillar tissues, 3 of 140 (2.1%) NPAs, 2 of 106 (1.9%) nasal swabs and 1 of 840 (0.1%) sera. WUPyV and KIPyV were detected in 5 (2.2%) and 0 tonsils, 1 (0.9%) and 4 (3.8%) nasal swabs and 0 and 2 (2.7%) fecal samples, respectively. The patients carrying in tonsils MCPyV were of significantly higher age (median 42 years) than those carrying WUPyV (4 years, p < 0.001). CONCLUSIONS: MCPyV DNA occurs in tonsils more frequently in adults than in children. By contrast, WUPyV DNA is found preferentially in children. MCPyV occurs also in nasal swabs and NPAs, in a frequency similar to that of KIPyV and WUPyV. The tonsil may be an initial site of WUPyV infection and a site of MCPyV persistence. |
format | Online Article Text |
id | pubmed-7172143 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71721432020-04-22 Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: Implications for respiratory transmission and latency Kantola, Kalle Sadeghi, Mohammadreza Lahtinen, Anne Koskenvuo, Minna Aaltonen, Leena-Maija Möttönen, Merja Rahiala, Jaana Saarinen-Pihkala, Ulla Riikonen, Pekka Jartti, Tuomas Ruuskanen, Olli Söderlund-Venermo, Maria Hedman, Klaus J Clin Virol Article BACKGROUND: Merkel cell polyomavirus (MCPyV) was discovered recently. It is considered a potential causative agent of Merkel cell carcinoma, a life-threatening skin cancer. OBJECTIVES: To study the prevalence of MCPyV in a large number of clinical samples of various types. Most of the samples were examined also for the other newly found polyomaviruses KI (KIPyV) and WU (WUPyV). STUDY DESIGN: Altogether 1390 samples from immunocompetent or immunocompromised patients, including (i) tonsillar tissues and sera from tonsillectomy patients; (ii) nasopharyngeal aspirates (NPAs) and sera from wheezing children and (iii) nasal swabs, sera and stools from febrile leukemic children were studied for MCPyV. The tonsils, nasal swabs and stools were also studied for KIPyV and WUPyV. RESULTS: MCPyV DNA was detected in 14 samples altogether; 8 of 229 (3.5%) tonsillar tissues, 3 of 140 (2.1%) NPAs, 2 of 106 (1.9%) nasal swabs and 1 of 840 (0.1%) sera. WUPyV and KIPyV were detected in 5 (2.2%) and 0 tonsils, 1 (0.9%) and 4 (3.8%) nasal swabs and 0 and 2 (2.7%) fecal samples, respectively. The patients carrying in tonsils MCPyV were of significantly higher age (median 42 years) than those carrying WUPyV (4 years, p < 0.001). CONCLUSIONS: MCPyV DNA occurs in tonsils more frequently in adults than in children. By contrast, WUPyV DNA is found preferentially in children. MCPyV occurs also in nasal swabs and NPAs, in a frequency similar to that of KIPyV and WUPyV. The tonsil may be an initial site of WUPyV infection and a site of MCPyV persistence. Elsevier B.V. 2009-08 2009-05-22 /pmc/articles/PMC7172143/ /pubmed/19464943 http://dx.doi.org/10.1016/j.jcv.2009.04.008 Text en Copyright © 2009 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Kantola, Kalle Sadeghi, Mohammadreza Lahtinen, Anne Koskenvuo, Minna Aaltonen, Leena-Maija Möttönen, Merja Rahiala, Jaana Saarinen-Pihkala, Ulla Riikonen, Pekka Jartti, Tuomas Ruuskanen, Olli Söderlund-Venermo, Maria Hedman, Klaus Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: Implications for respiratory transmission and latency |
title | Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: Implications for respiratory transmission and latency |
title_full | Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: Implications for respiratory transmission and latency |
title_fullStr | Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: Implications for respiratory transmission and latency |
title_full_unstemmed | Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: Implications for respiratory transmission and latency |
title_short | Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: Implications for respiratory transmission and latency |
title_sort | merkel cell polyomavirus dna in tumor-free tonsillar tissues and upper respiratory tract samples: implications for respiratory transmission and latency |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172143/ https://www.ncbi.nlm.nih.gov/pubmed/19464943 http://dx.doi.org/10.1016/j.jcv.2009.04.008 |
work_keys_str_mv | AT kantolakalle merkelcellpolyomavirusdnaintumorfreetonsillartissuesandupperrespiratorytractsamplesimplicationsforrespiratorytransmissionandlatency AT sadeghimohammadreza merkelcellpolyomavirusdnaintumorfreetonsillartissuesandupperrespiratorytractsamplesimplicationsforrespiratorytransmissionandlatency AT lahtinenanne merkelcellpolyomavirusdnaintumorfreetonsillartissuesandupperrespiratorytractsamplesimplicationsforrespiratorytransmissionandlatency AT koskenvuominna merkelcellpolyomavirusdnaintumorfreetonsillartissuesandupperrespiratorytractsamplesimplicationsforrespiratorytransmissionandlatency AT aaltonenleenamaija merkelcellpolyomavirusdnaintumorfreetonsillartissuesandupperrespiratorytractsamplesimplicationsforrespiratorytransmissionandlatency AT mottonenmerja merkelcellpolyomavirusdnaintumorfreetonsillartissuesandupperrespiratorytractsamplesimplicationsforrespiratorytransmissionandlatency AT rahialajaana merkelcellpolyomavirusdnaintumorfreetonsillartissuesandupperrespiratorytractsamplesimplicationsforrespiratorytransmissionandlatency AT saarinenpihkalaulla merkelcellpolyomavirusdnaintumorfreetonsillartissuesandupperrespiratorytractsamplesimplicationsforrespiratorytransmissionandlatency AT riikonenpekka merkelcellpolyomavirusdnaintumorfreetonsillartissuesandupperrespiratorytractsamplesimplicationsforrespiratorytransmissionandlatency AT jarttituomas merkelcellpolyomavirusdnaintumorfreetonsillartissuesandupperrespiratorytractsamplesimplicationsforrespiratorytransmissionandlatency AT ruuskanenolli merkelcellpolyomavirusdnaintumorfreetonsillartissuesandupperrespiratorytractsamplesimplicationsforrespiratorytransmissionandlatency AT soderlundvenermomaria merkelcellpolyomavirusdnaintumorfreetonsillartissuesandupperrespiratorytractsamplesimplicationsforrespiratorytransmissionandlatency AT hedmanklaus merkelcellpolyomavirusdnaintumorfreetonsillartissuesandupperrespiratorytractsamplesimplicationsforrespiratorytransmissionandlatency |